PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Molecular structure reveals how HIV infects cells

The landmark finding will guide future drug design

2013-09-13
(Press-News.org) SHANGHAI, CHINA, AND LA JOLLA, CA – In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also showed where maraviroc, an HIV drug, attaches to cells and blocks HIV's entry.

"These structural details should help us understand more precisely how HIV infects cells, and how we can do better at blocking that process with next-generation drugs," said Beili Wu, PhD, professor at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Wu was the senior investigator for the study, which was published in Science Express on September 12, 2013.

The study, which focused on the CCR5 receptor, was supported by both US and Chinese research funding agencies. "International collaborations like this one are increasingly needed to solve big problems in science," said study co-author Raymond C. Stevens, PhD, a professor at The Scripps Research Institute (TSRI) in California. "Now that we have both human CXCR4 and CCR5 HIV co-receptor three-dimensional structures, it is likely we will see the next generation of HIV therapeutics."

A Major Target

The CCR5 receptor is one of the most sought-after targets for new anti-HIV drugs. Although the AIDS-causing virus was initially discovered to infect cells via another receptor, CD4, researchers found in 1996 that HIV infection also requires a co-receptor—usually CCR5, which sits alongside CD4 on a variety of immune cells.

CCR5's importance to HIV infection is underscored by the fact that certain genetic variants of it can dramatically raise or lower HIV infection risk, as well as the speed of the disease process after infection. One shortened CCR5 variant, found in about 10 percent of Europeans, is not expressed at all on immune cell surfaces—and people who produce only this variant are almost invulnerable to HIV infection.

Scientists therefore have sought to develop anti-HIV drugs that block the virus from binding to CCR5 or otherwise render the receptor inactive. Yet only a handful of CCR5-inhibiting compounds have been developed so far—and no one knows exactly how they work.

"One thing that we've lacked is a high-resolution molecular 'picture' of the CCR5 receptor structure that we can use for precise drug design," Wu said.

A Six-Year Quest

Wu came to the Stevens laboratory at TSRI in 2007 to conduct postdoctoral research on the two HIV co-receptors CCR5 and the alternate HIV co-receptor CXCR4. A minority of HIV strains use CXCR4 instead of CCR5 as a co-receptor with CD4 for their initial infiltration of cells.

"Her goal from the beginning was to determine the structures and understand the functions of these two HIV co-receptors and she was very determined, which was inspiring," said Stevens.

Wu spent her postdoctoral years focusing on CXCR4, which posed fewer technical challenges than CCR5. Her landmark study of the CXCR4 structure was published in Science in 2010. After moving back to China to start her own laboratory, she returned to the "unfinished business" of the CCR5 structure.

Both CCR5 and CXCR4 belong to a large family of cell receptors known as G protein-coupled receptors (GPCRs). GPCRs are notoriously hard to produce in useful amounts for structural analysis. With their floppy structures, they are also very hard to coax into the ordered, solid lineups of individual molecules—"crystals"—needed for structure determination by X-ray crystallography. Eventually, however, with help from insights gained during the CXCR4 project, Wu as a new professor and her young team of students used a novel "fusion partner" molecule that would hold CCR5 proteins together enough to form usable crystals.

As in most receptor-structure projects, Wu and her colleagues further stabilized CCR5 with a compound that is known to bind to it, in this case the Pfizer drug maraviroc (sold under the brand name Selzentry®, or Celsentri® outside the US). Marketed for HIV infection since 2007, maraviroc grabs hold of CCR5 in a way that prevents HIV from using the receptor to get into cells. "Maraviroc was thought to lock CCR5 into an inactive conformation, and so we wanted to 'see' that conformation at high resolution," said Wu.

The resulting crystallography data provided that fine-grained picture of CCR5's HIV-resistant conformation. The data also revealed maraviroc's precise binding site on CCR5—a site from which the drug molecule clearly influences how the receptor works, even though it is separate from the sites on the receptor that are thought to be used by HIV. The maraviroc binding site is also different from the site used by CCR5's natural binding-partners, a set of immune proteins called chemokines. Maraviroc thus appears to work against HIV indirectly: not by physically blocking the virus, but by locking the receptor structure into an HIV-insensitive conformation.

"Structural details can offer tremendous insight into how proteins and drugs work, also aiding the development of therapeutic agents," said Peter Preusch, PhD, of the National Institute of General Medical Sciences, which helped fund the research along with another component of the National Institutes of Health, the National Institute of Allergy and Infectious Diseases. "This study provides knowledge about the interactions between maraviroc and CCR5, a target for anti-HIV therapy, that helps us understand how the drug works at the molecular level and could enable further explorations of HIV biology and approaches to improve drugs targeting such interactions."

Useful Insights

Comparison of the CCR5 structure with the previously determined CXCR4 structure also provided hints about an important aspect of HIV evolution during infections. Most HIV infections start by using only CCR5 as a co-receptor for cell entry, but in time the virus often switches its co-receptor usage from CCR5 to CXCR4. That opens up more cell types to HIV infection, and the further spread of the virus inside the body is liable to speed up the disease progression towards full-blown AIDS and death.

The new data suggest that the distinction between CCR5 and CXCR4 as co-receptors for HIV infection boils down to relatively subtle differences in structural shapes and electric charge distributions in the HIV binding region—differences that will be of interest to HIV drug developers.

"Knowing the CXCR4 structure and now the CCR5 structure at this level of detail should accelerate the development of drugs that can block HIV by using both of these co-receptors," said Wu.

She and her colleagues now plan to follow up with structural studies of CCR5 and CXCR4 in complex with the HIV envelope protein gp120 and CD4 to obtain even more informative pictures of the process of viral infection.



INFORMATION:

In addition to Wu and Stevens, the contributors to the study, "Structure of the CCR5 Chemokine Receptor – HIV Entry Inhibitor Maraviroc Complex," were lead author Qiuxiang Tan and Ya Zhu, Jian Li, Zhuxi Chen, Tingting Li, Limin Ma, Jing Li, Wenru Zhang, Xin Xie, Huaiyu Yang, Hualiang Jiang, Hong Liu and Qiang Zhao, all of the Shanghai Institute of Materia Medica; Gye Won Han, Gustavo Fenalti and Vadim Cherezov of TSRI; and Irina Kufareva of the University of California at San Diego.

The study was funded in part by the National Basic Research Program of China (grants 2012CB518000 and 2012CB910400), the National Institutes of Health (R01 AI100604, U54 GM094618 and a supplement to U54 GM094618 as part of the U.S.-China Biomedical Collaborative Research Program), the National Science Foundation of China (grants 31270766, 81161120425, and 81025017) and the Shanghai Science and Technology Committee (grants 11JC1414800 and 12PJ1410500).

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see http://www.scripps.edu.

About Shanghai Institute of Materia Medica, Chinese Academy of Sciences

The Shanghai Institute of Materia Medica (SIMM) at the Chinese Academy of Sciences emerged from the Institute of Materia Medica of the Peking Academy of Sciences, founded in 1932. (SIMM) is currently located in the Zhang Jiang Hi-Tech Park, Pudong New District, Shanghai. The institute's mission is to provide a comprehensive single-site solution to drug discovery and development. By combining basic and applied research in chemistry and biological disciplines, SIMM carries out modern drug discovery, as well as studies supporting identification of the purified ingredients responsible for the activity of traditional Chinese medicines. SIMM is also involved in the discovery of new therapeutic targets and carries out comprehensive pre-clinical evaluation of drug candidates, while also promoting commercialization, thereby playing a key role in building China's drug innovation capabilities.



ELSE PRESS RELEASES FROM THIS DATE:

Ready for its close-up: 1 of HIV's entrance points

2013-09-13
Scientists have gotten the first close look at one of two co-receptors HIV uses to get its foot in the door of the immune system, a new study reports. Their insights could lead to better HIV drugs. CCR5, a receptor on the surface of human cells, is one of two main entry points the HIV virus uses to initiate its attack on the human immune system; by binding to it, an HIV protein can fuse to the cell membrane beneath, ultimately digging its way inside the cell. The other receptor that HIV uses to perform this feat is CXCR4. Both CCR5 and CXCR4 belong to a family of ...

Local animals' role in human drug-resistant Salmonella may previously have been overstated

2013-09-13
A new study has shown that, contrary to popular belief, local domestic animals are unlikely to be the major source of antibiotic resistant Salmonella in humans. The result comes from a detailed study of DNA from more than 370 Salmonella samples collected over a 22-year period. By studying the genetic variation in the Salmonella bacteria and their drug resistance genes, researchers found that distinguishable bacterial populations exist in human and animal populations living side by side. Antibiotic resistance is considered to be one of the most important dangers to human ...

International structures needed for equitable access to DNA identification after disaster

2013-09-13
PITTSBURGH— The April 2013 collapse of the Rana Plaza Factory Building in Bangladesh, in which more than 1,130 people were killed, is only the latest in a long line of events that has made plain the plight of the families whose loved ones go missing after conflict and disaster. In a new paper published in "Science," Carnegie Mellon University and the University of Pittsburgh ethics, policy and human rights experts argue that international structures are needed to promote more equal access to forensic identification technologies, ensure their fair and efficient use, ...

Functioning 'mechanical gears' seen in nature for the first time

2013-09-13
The juvenile Issus - a plant-hopping insect found in gardens across Europe - has hind-leg joints with curved cog-like strips of opposing 'teeth' that intermesh, rotating like mechanical gears to synchronise the animal's legs when it launches into a jump. The finding demonstrates that gear mechanisms previously thought to be solely man-made have an evolutionary precedent. Scientists say this is the "first observation of mechanical gearing in a biological structure". Through a combination of anatomical analysis and high-speed video capture of normal Issus movements, scientists ...

Genes linked to being right- or left-handed identified

2013-09-13
A genetic study has identified a biological process that influences whether we are right handed or left handed. Scientists at the Universities of Oxford, St Andrews, Bristol and the Max Plank Institute in Nijmegen, the Netherlands, found correlations between handedness and a network of genes involved in establishing left-right asymmetry in developing embryos. 'The genes are involved in the biological process through which an early embryo moves on from being a round ball of cells and becomes a growing organism with an established left and right side,' explains first ...

Antibiotic reduction can be achieved through low cost information campaigns, find researchers

2013-09-13
A local low-cost information campaign mainly targeted at citizens and involving doctors and pharmacists can significantly decrease total antibiotic prescribing, finds a paper published today on bmj.com. The excessive use of antibiotics is associated with resistance to these drugs and an increasing threat to global health. Antibiotics are also often unnecessarily and inappropriately prescribed. This is an issue that has been frequently addressed by health information campaigns. Campaigns can be moderately effective in restricting the excessive use of antibiotics although ...

Current pledges put over 600 million people at risk of higher water scarcity

2013-09-13
Our current pledges to reduce greenhouse gas emissions, which are projected to set the global mean temperature increase at around 3.5°C above pre-industrial levels, will expose 668 million people worldwide to new or aggravated water scarcity. This is according to a new study published today, 13 September, in IOP Publishing's journal Environmental Research Letters, which has calculated that a further 11 per cent of the world's population, taken from the year 2000, will live in water-scarce river basins or, for those already living in water-scarce regions, find that the ...

New research shows link between rates of gun ownership and homicides

2013-09-13
(Boston) -- A new study from the American Journal of Public Heath shows that U.S. states with higher estimated rates of gun ownership experience a higher number of firearms-related homicides. The study, led by a Boston University School of Public Health researcher, examines the National Rifle Association's (NRA) claim that increased gun ownership does not lead to increased gun violence. It is the largest study conducted to date into the correlation between gun ownership and firearms violence, and the first to comprehensively examine the issue since the tragic shooting ...

Movement of marine life follows speed and direction of climate change

2013-09-13
VIDEO: New research based at Princeton University shows that the trick to predicting when and where sea animals will relocate due to climate change is to follow the pace and direction... Click here for more information. Scientists expect climate change and warmer oceans to push the fish that people rely on for food and income into new territory. Predictions of where and when species will relocate, however, are based on broad expectations about how animals will move and have ...

The UK is not investing enough in research into multi-drug resistant infections, say researchers

2013-09-13
Although emergence of antimicrobial resistance severely threatens our future ability to treat many infections, the UK infection-research spend targeting this important area is still unacceptably small, say a team of researchers led by Michael Head of UCL (University College London). Their study is published online today in the Journal of Antimicrobial Chemotherapy. This study is the first systematic analysis of research funding for infectious disease research, and for antimicrobial resistance, in the UK between 1997 and 2010. There were 6,165 studies identified that ...

LAST 30 PRESS RELEASES:

Exploring the systematic anticancer mechanism in selected medicinal plants

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials

Scarlet Macaw parents ‘play favorites,’ purposefully neglect younger chicks

One gene provides diagnoses for 30 patients whose condition was unexplained for years

Current practice and emerging endoscopic technology in the diagnosis of colorectal cancer

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders

Key pathway leading to neurodegeneration in early stages of ALS identified

Ferroptosis in regulating treatment tolerance of digestive system tumors

A promising future in pancreatic incidentaloma detection

Stabilizing lithium-ion batteries: The vanadium touch

Innovative approaches to the surgical challenges in the management of gastroschisis

Mouse models for the study of liver fibrosis regression in vivo and ex vivo

At Fortune Global Forum 2024, Alex Zhavoronkov PhD, Founder and CEO of Insilico Medicine, discusses AI business potential

Exploring circulating tumor cells: Detection methods and biomarkers for clinical evaluation in hepatocellular carcinoma

New material to make next generation of electronics faster and more efficient

Research update: Chalk-coated textiles cool in urban environments

New take on immunotherapy reinvigorates T cells by blocking uptake of energy-sapping cancer byproducts

How much climate change is in the weather?

Flagship AI-ready dataset released in type 2 diabetes study

Shaking it up: An innovative method for culturing microbes in static liquid medium

Greener and cleaner: Yeast-green algae mix improves water treatment

Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac

CIDEC as a novel player in abdominal aortic aneurysm formation

Artificial intelligence: a double-edged sword for the environment?

Current test accommodations for students with blindness do not fully address their needs

Wide-incident-angle wideband radio-wave absorbers boost 5G and beyond 5G applications

A graph transformer with boundary-aware attention for semantic segmentation

C-Path announces key leadership appointments in neurodegenerative disease research

First-of-its-kind analysis of U.S. national data reveals significant disparities in individual well-being as measured by lifespan, education, and income

Exercise programs help cut new mums’ ‘baby blues’ severity and major depression risk

[Press-News.org] Molecular structure reveals how HIV infects cells
The landmark finding will guide future drug design